Statin-associated muscle symptoms (SAMS) are commonly encountered.
Strategies are rechallenge, switch, nondaily statin dosing, or nonstatins.
Tolerability of each of these strategies is over 60%; efficacy is variable.
Several limitations are still encountered in the management of patients with SAMS.
Ultimately, patient involvement determines which strategy is most acceptable.